5-fluorouracil Plus Panitumumab (Anti-EGFR) and Sotorasib (KRAS G12C Inhibitor) in First-line Treatment of Patients Non-eligible for a Doublet/Triplet Chemotherapy With Advanced Unresectab

Clinical trial NCT07124884 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07124884
Sponsor: Federation Francophone de Cancerologie Digestive
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Carcinoma KRAS G12C Mutation Unresectable Colorectal Cancer

Start date: 2025-08-31
Primary completion: 2030-06-30
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.